Bay Colony Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $831K | Sell |
1,583
-93
| -6% | -$48.8K | 0.11% | 167 |
|
|
2025
Q1 | $1.07M | Buy |
1,676
+392
| +31% | +$250K | 0.16% | 135 |
|
|
2024
Q4 | $915K | Sell |
1,284
-545
| -30% | -$388K | 0.14% | 153 |
|
|
2024
Q3 | $1.92M | Buy |
1,829
+145
| +9% | +$152K | 0.29% | 78 |
|
|
2024
Q2 | $1.77M | Buy |
1,684
+476
| +39% | +$500K | 0.3% | 75 |
|
|
2024
Q1 | $1.16M | Sell |
1,208
-100
| -8% | -$96.2K | 0.2% | 110 |
|
|
2023
Q4 | $1.15M | Buy |
1,308
+15
| +1% | +$13.2K | 0.23% | 99 |
|
|
2023
Q3 | $1.06M | Sell |
1,293
-4
| -0.3% | -$3.29K | 0.26% | 92 |
|
|
2023
Q2 | $932K | Sell |
1,297
-7
| -0.5% | -$5.03K | 0.23% | 106 |
|
|
2023
Q1 | $1.06M | Sell |
1,304
-121
| -8% | -$98.2K | 0.28% | 90 |
|
|
2022
Q4 | $1.03M | Sell |
1,425
-802
| -36% | -$579K | 0.27% | 96 |
|
|
2022
Q3 | $1.53M | Sell |
2,227
-10
| -0.4% | -$6.89K | 0.46% | 50 |
|
|
2022
Q2 | $1.3M | Sell |
2,237
-442
| -16% | -$257K | 0.33% | 73 |
|
|
2022
Q1 | $1.87M | Sell |
2,679
-243
| -8% | -$170K | 0.45% | 55 |
|
|
2021
Q4 | $1.85M | Buy |
2,922
+115
| +4% | +$72.6K | 0.53% | 51 |
|
|
2021
Q3 | $1.7M | Buy |
2,807
+393
| +16% | +$238K | 0.56% | 48 |
|
|
2021
Q2 | $1.35M | Sell |
2,414
-3
| -0.1% | -$1.68K | 0.45% | 63 |
|
|
2021
Q1 | $1.14M | Buy |
2,417
+842
| +53% | +$399K | 0.44% | 65 |
|
|
2020
Q4 | $761K | Buy |
1,575
+449
| +40% | +$217K | 0.4% | 76 |
|
|
2020
Q3 | $630K | Buy |
+1,126
| New | +$630K | 0.39% | 79 |
|
|
2020
Q1 | – | Sell |
-693
| Closed | -$249K | – | 235 |
|
|
2019
Q4 | $249K | Buy |
+693
| New | +$249K | 0.16% | 210 |
|